MetLife Investment Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,033
| Closed | -$20.7K | – | 2895 |
|
2025
Q1 | $20.7K | Sell |
2,033
-5,067
| -71% | -$51.7K | ﹤0.01% | 2747 |
|
2024
Q4 | $99.1K | Hold |
7,100
| – | – | ﹤0.01% | 2628 |
|
2024
Q3 | $138K | Buy |
7,100
+4,000
| +129% | +$78K | ﹤0.01% | 2473 |
|
2024
Q2 | $57.7K | Buy |
+3,100
| New | +$57.7K | ﹤0.01% | 2737 |
|
2023
Q2 | – | Sell |
-4,057
| Closed | -$42.8K | – | 2971 |
|
2023
Q1 | $42.8K | Sell |
4,057
-2,279
| -36% | -$24K | ﹤0.01% | 2728 |
|
2022
Q4 | $215K | Hold |
6,336
| – | – | ﹤0.01% | 2206 |
|
2022
Q3 | $304K | Hold |
6,336
| – | – | ﹤0.01% | 2011 |
|
2022
Q2 | $361K | Buy |
6,336
+6,097
| +2,551% | +$348K | ﹤0.01% | 1885 |
|
2022
Q1 | $19.4K | Buy |
+239
| New | +$19.4K | ﹤0.01% | 2710 |
|
2021
Q4 | – | Sell |
-5,887
| Closed | -$1.59M | – | 2534 |
|
2021
Q3 | $1.59M | Sell |
5,887
-186
| -3% | -$50.1K | 0.01% | 946 |
|
2021
Q2 | $1.56M | Sell |
6,073
-201
| -3% | -$51.7K | 0.01% | 964 |
|
2021
Q1 | $1.88M | Sell |
6,274
-271
| -4% | -$81.3K | 0.02% | 891 |
|
2020
Q4 | $1.67M | Sell |
6,545
-283
| -4% | -$72.2K | 0.02% | 914 |
|
2020
Q3 | $1.7M | Sell |
6,828
-219
| -3% | -$54.5K | 0.02% | 788 |
|
2020
Q2 | $2.45M | Buy |
7,047
+315
| +5% | +$109K | 0.03% | 632 |
|
2020
Q1 | $1.8M | Hold |
6,732
| – | – | 0.02% | 653 |
|
2019
Q4 | $2.18M | Buy |
6,732
+3,552
| +112% | +$1.15M | 0.02% | 775 |
|
2019
Q3 | $869K | Sell |
3,180
-23
| -0.7% | -$6.28K | 0.01% | 1139 |
|
2019
Q2 | $1.71M | Sell |
3,203
-95
| -3% | -$50.7K | 0.02% | 880 |
|
2019
Q1 | $1.66M | Hold |
3,298
| – | – | 0.02% | 888 |
|
2018
Q4 | $1.63M | Sell |
3,298
-45
| -1% | -$22.2K | 0.02% | 841 |
|
2018
Q3 | $3.06M | Buy |
3,343
+181
| +6% | +$166K | 0.03% | 657 |
|
2018
Q2 | $2.32M | Sell |
3,162
-4,530
| -59% | -$3.32M | 0.03% | 742 |
|
2018
Q1 | $12.3M | Buy |
7,692
+3,228
| +72% | +$5.15M | 0.14% | 132 |
|
2017
Q4 | $4M | Buy |
+4,464
| New | +$4M | 0.05% | 469 |
|